Use access key #2 to skip to page content.
$93.72 -1.12 (-1.18%)
10/7/2008 3:45 PM

United Therapeutics Corp (UTHR)

CAPS Rating:
****

A biotechnology company focused on the development and commercialization of innovative therapeutic products for patients with chronic and life-threatening cardiovascular, cancer and infectious diseases.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating UTHR

Add Stock to Watchlist

What the Community Thinks

Total Members

128 Outperforms
9 Underperforms
 

All-Stars

31 Outperforms
2 Underperforms
 

Wall Street

11 Outperforms
1 Underperforms
 

Members bullish on UTHR are also bullish on:

Members bearish on UTHR are also bearish on:

Ticker Tags

Small Cap (1922), Biotechnology (295), Drug Manufacturers - Other (105)
Suggest a tag

United Therapeutics Corp At A Glance

Current Price: $93.72
Last Trade Time: 10/7/2008 3:45 PM
Open: $0.00
Previous Close: $94.84
Daily Range: $93.22 - $97.94
52-Week Range: $65.03 - $117.82
Volume: 789,400
Market Cap: $2.46B
P/E Ratio: 55.27
Compare Our Special Broker Offers!

Stock Trends

UTHR VS S&P 500 (SPY)

UTHR 12 month chart vs. S&P

News & Discussion Boards

Other News Headlines for UTHR

More Headlines...

Top Bull Pitch

Recs

1

United Therapeutics Corp (UTHR)

Avatar jennings2 (21.37) Submitted: 5/03/07 3:32 PM

UTHR owns the US rights to Ovarex, an immune based therapy for ovarian cancer originated from virexx corporation, in ph 3 trials. since I can't put forward REX, due to CAPS rules, UTHR is my placeholder. I think Ovarex has a very good chance of being another Provenge type cancer treatment

Replies: 1 | Reply | Permalink

Top Bear Pitch

Recs

1

United Therapeutics Corp (UTHR)

Avatar cnbr1 (45.53) Submitted: 10/04/06 9:44 AM

New PAH drugs will reduce UTHR's market; generic Flolan, Ambrisentan etc.

Replies: 0 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 11 :   1 2 3 Next »

Recs

0

 (UTHR)

Avatar nysegal (67.14) Submitted: 8/05/08 2:24 AM : Outperform Start Price: $111.57 UTHR Score: 4.64

UTHR is a terrific growth stock; accellerating earnings -- 80% in 08 and 68% in 09; recently reported fantastic earnings above street estimates.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (UTHR)

Avatar BfloBull (93.94) Submitted: 5/12/08 2:55 PM : Outperform Start Price: $92.90 UTHR Score: 29.66

LT Growth: 44%





PEG Ratio: .74





EPS Surp: + Past 3 Qtrs





Money Flow UP





Janus, Driehaus, Col Circle, SJ, RS, Copper Rock, Alger





= BUY

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (UTHR)

Avatar ThxUT (36.98) Submitted: 3/13/08 12:29 PM : Outperform Start Price: $79.52 UTHR Score: 41.23

UT leads the market in pulmonary hypertension with rapid growth and a better product than all the competitors.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (UTHR)

Avatar SteelBreez99 (< 20) Submitted: 12/11/07 5:47 PM : Outperform Start Price: $108.00 UTHR Score: 20.56

VALUE LINES - TIMELY STOCKS IN TIMELY INDUSTRIES

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (UTHR)

Avatar qasamm (90.41) Submitted: 12/11/07 1:45 PM : Outperform Start Price: $107.37 UTHR Score: 21.70

Amazing leadership- many great suprises found in each annual report (no debt, diversity of pipeline, etc.)

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 11 :   1 2 3 Next »

Wall Street

Results 1 - 12 of 12  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackJefferies < 20 09/24/08 Outperform NS $109.90-14.72%-16.19%+1.47
TrackStanfordRes 53.93 09/19/08 Outperform NS $110.50-15.19%-21.39%+6.21
TrackZacks 78.83 08/20/08 Underperform 3M $104.68-10.47%-21.59%-11.12 Toggle the visibility of 60-Second Pitch and replies
TrackPiperJaff 59.14 08/12/08 Underperform NS $109.31-14.26%-23.24%-8.98
TrackLadenburg 98.21 08/01/08 Outperform NS $114.05-17.83%-21.17%+3.34
TrackCollinsStew < 20 02/20/08 Outperform NS $85.88+9.13%-25.50%+34.62
TrackJimCramer 83.84 11/02/07 Outperform 3W $102.85-8.88%-33.84%+24.97
TrackRodmanRen 29.54 08/01/07 Outperform NS $70.12+33.66%-31.10%+64.76
TrackLeerinkSwan 97.08 05/18/07 Outperform NS $66.85+40.19%-34.16%+74.35
TrackCitigroup < 20 05/08/07 Outperform NS $61.04+53.54%-33.57%+87.11
TrackLehmanBros < 20 03/02/07 Outperform NS $55.21+69.75%-28.58%+98.33
TrackPZK < 20 02/21/07 Outperform NS $56.46+65.99%-31.19%+97.18
TrackPacificGrow 27.91 02/20/07 Outperform NS $57.01+64.39%-31.48%+95.87

Results 1 - 12 of 12  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners